Loring Wolcott & Coolidge Fiduciary Advisors LLP Edwards Lifesciences Corp Transaction History
Loring Wolcott & Coolidge Fiduciary Advisors LLP
- $10.5 Billion
- Q2 2024
A detailed history of Loring Wolcott & Coolidge Fiduciary Advisors LLP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Loring Wolcott & Coolidge Fiduciary Advisors LLP holds 105,844 shares of EW stock, worth $6.6 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
105,844
Previous 133,302
20.6%
Holding current value
$6.6 Million
Previous $12.7 Million
23.25%
% of portfolio
0.09%
Previous 0.12%
Shares
30 transactions
Others Institutions Holding EW
# of Institutions
1,386Shares Held
453MCall Options Held
3.85MPut Options Held
3.34M-
Vanguard Group Inc Valley Forge, PA53MShares$3.3 Billion0.1% of portfolio
-
Black Rock Inc. New York, NY52.4MShares$3.27 Billion0.12% of portfolio
-
State Street Corp Boston, MA26.8MShares$1.67 Billion0.12% of portfolio
-
Brown Advisory Inc16.6MShares$1.04 Billion2.18% of portfolio
-
Alliancebernstein L.P. New York, NY16.4MShares$1.02 Billion0.57% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $38.6B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...